219 related articles for article (PubMed ID: 30108120)
21. Ipsilateral metastatic choroidal melanoma responds to systemic immunotherapy.
Morkos M; Jain P; Pavlick AC; Finger PT
Eur J Ophthalmol; 2020 Sep; 30(5):NP69-NP73. PubMed ID: 30943789
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma.
Sezen D; Patel RR; Tang C; Onstad M; Nagarajan P; Patel SP; Welsh JW; Lin LL
Gynecol Oncol; 2021 Jun; 161(3):645-652. PubMed ID: 33795130
[TBL] [Abstract][Full Text] [Related]
23. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.
Rozeman EA; Menzies AM; van Akkooi ACJ; Adhikari C; Bierman C; van de Wiel BA; Scolyer RA; Krijgsman O; Sikorska K; Eriksson H; Broeks A; van Thienen JV; Guminski AD; Acosta AT; Ter Meulen S; Koenen AM; Bosch LJW; Shannon K; Pronk LM; Gonzalez M; Ch'ng S; Grijpink-Ongering LG; Stretch J; Heijmink S; van Tinteren H; Haanen JBAG; Nieweg OE; Klop WMC; Zuur CL; Saw RPM; van Houdt WJ; Peeper DS; Spillane AJ; Hansson J; Schumacher TN; Long GV; Blank CU
Lancet Oncol; 2019 Jul; 20(7):948-960. PubMed ID: 31160251
[TBL] [Abstract][Full Text] [Related]
24. Pseudoprogression with subsequent complete response and severe thrombocytopenia to checkpoint inhibitor immunotherapy in a patient with advanced mucosal melanoma of the sinonasal cavity.
Philipp M; Frischhut N; Tschachler A; Steinkohl F; Weinlich G; Schmuth M; Nguyen VA
Anticancer Drugs; 2018 Oct; 29(9):914-918. PubMed ID: 29952773
[TBL] [Abstract][Full Text] [Related]
25. A Case of Vanishing Brain Metastasis in a Melanoma Patient on Nivolumab.
Basnet A; Saad N; Benjamin S
Anticancer Res; 2016 Sep; 36(9):4795-8. PubMed ID: 27630330
[TBL] [Abstract][Full Text] [Related]
26. Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: two case reports.
Schliep S; Agaimy A; Cavallaro A; Kiesewetter F; Schuler G; Heinzerling L
J Immunother Cancer; 2018 Jan; 6(1):2. PubMed ID: 29332608
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172).
Schadendorf D; Ascierto PA; Haanen J; Espinosa E; Demidov L; Garbe C; Guida M; Lorigan P; Chiarion-Sileni V; Gogas H; Maio M; Fierro MT; Hoeller C; Terheyden P; Gutzmer R; Guren TK; Bafaloukos D; Rutkowski P; Plummer R; Waterston A; Kaatz M; Mandala M; Marquez-Rodas I; Muñoz-Couselo E; Dummer R; Grigoryeva E; Young TC; Nathan P
Eur J Cancer; 2019 Nov; 121():144-153. PubMed ID: 31581055
[TBL] [Abstract][Full Text] [Related]
28. Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.
Rosner S; Kwong E; Shoushtari AN; Friedman CF; Betof AS; Brady MS; Coit DG; Callahan MK; Wolchok JD; Chapman PB; Panageas KS; Postow MA
Cancer Med; 2018 Mar; 7(3):690-697. PubMed ID: 29468834
[TBL] [Abstract][Full Text] [Related]
29. Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report.
Casadevall D; Vidal J; Gallardo F; Zuccarino F; Arumí-Uría M; Dalmases A; Bellosillo B; Montagut C
J Med Case Rep; 2016 Jun; 10(1):158. PubMed ID: 27255157
[TBL] [Abstract][Full Text] [Related]
30. Case of desmoplastic melanoma with lung metastasis maintaining complete response after cessation of nivolumab.
Murayama A; Itoh M; Ito K; Tanito K; Ishida K; Nobeyama Y; Nakagawa H
J Dermatol; 2017 Mar; 44(3):e17-e18. PubMed ID: 27461747
[No Abstract] [Full Text] [Related]
31. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
Goldberg SB; Gettinger SN; Mahajan A; Chiang AC; Herbst RS; Sznol M; Tsiouris AJ; Cohen J; Vortmeyer A; Jilaveanu L; Yu J; Hegde U; Speaker S; Madura M; Ralabate A; Rivera A; Rowen E; Gerrish H; Yao X; Chiang V; Kluger HM
Lancet Oncol; 2016 Jul; 17(7):976-983. PubMed ID: 27267608
[TBL] [Abstract][Full Text] [Related]
32. Treatment patterns and outcomes for patients with unresectable stage III and metastatic melanoma in the USA.
Tarhini A; Atzinger C; Gupte-Singh K; Johnson C; Macahilig C; Rao S
J Comp Eff Res; 2019 May; 8(7):461-473. PubMed ID: 30832505
[No Abstract] [Full Text] [Related]
33. Simultaneous long-lasting regression of multiple nevi and melanoma metastases after ipilimumab therapy.
Plaquevent M; Greliak A; Pinard C; Duval-Modeste AB; Joly P
Melanoma Res; 2019 Jun; 29(3):311-312. PubMed ID: 31026247
[TBL] [Abstract][Full Text] [Related]
34. Impact of cranial stereotactic radiotherapy associated with immunotherapy with nivolumab and ipilimumab on overall survival in patients with melanoma brain metastases: a real-world evidence.
de Castro DG; Teixeira CHA; Gondim GRM; Aguilar PB; Costa MASB; Jorge TWC; Morais Hanriot R
Clin Transl Oncol; 2022 Sep; 24(9):1828-1830. PubMed ID: 35546648
[TBL] [Abstract][Full Text] [Related]
35. Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma.
Abdel-Rahman O
Melanoma Res; 2019 Feb; 29(1):53-58. PubMed ID: 30362976
[TBL] [Abstract][Full Text] [Related]
36. A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity.
Chan PY; Hall P; Hay G; Cohen VML; Szlosarek PW
Pigment Cell Melanoma Res; 2017 Jan; 30(6):558-562. PubMed ID: 28640512
[TBL] [Abstract][Full Text] [Related]
37. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.
Kreft S; Gesierich A; Eigentler T; Franklin C; Valpione S; Ugurel S; Utikal J; Haferkamp S; Blank C; Larkin J; Garbe C; Schadendorf D; Lorigan P; Schilling B
Eur J Cancer; 2019 Jul; 116():207-215. PubMed ID: 31212163
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune polyradiculitis due to combination immunotherapy with ipilimumab and nivolumab for the treatment of metastatic melanoma.
Lasocki A; Smith K
J Clin Neurosci; 2020 Apr; 74():240-241. PubMed ID: 31983645
[TBL] [Abstract][Full Text] [Related]
40. Impressive objective response in a patient with extensive metastatic melanoma including the brain.
Del Vecchio M; Canova S; Messina A; Bajetta E
Melanoma Res; 2007 Oct; 17(5):332-4. PubMed ID: 17885590
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
